PAULA HARDEMAN: Open Payments
NPI 1023076262 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,191 in 13 payments from 4 companies in 2025. Trend: 2023 $1,008 · 2024 $0 · 2025 $9,191
Consulting: $7,899Travel & lodging: $942Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $6,222 |
| TG Therapeutics, Inc. | 5 | $1,659 |
| EMD Serono, Inc. | 2 | $1,160 |
| Biogen, Inc. | 1 | $150 |
Products named: BRIUMVI, TYSABRI.
Industry payments across TX — which companies pay providers there.
